Bartolome Burguera, MD
Endocrinology, Diabetes & Metabolism · Cleveland, OHNPI 1093148983
Payments from drug & device makers
Across 528 payments — averaging $5792.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$3M
- Medical Device Business Services, Inc.$18K
- Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C.$14K
- Novo Nordisk$2K
- Abbott$1K
- Janssen Scientific Affairs, LLC$226
- plus $148 from 2 others
Across 10 payments — averaging $518.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$4K
- Novo Nordisk$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 494 | $3,023,184 |
| Medical Device Business Services, Inc. | 14 | $17,993 |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | 8 | $14,160 |
| Novo Nordisk | 7 | $1,921 |
| Abbott | 1 | $1,000 |
| Janssen Scientific Affairs, LLC | 2 | $226 |
| Medtronic | 1 | $135 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,058,631 in reported general payments places this provider in the 95th percentile of 312 endocrinology, diabetes & metabolism providers in Ohio.
See all endocrinology, diabetes & metabolism providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Cleveland
- Kevin PantaloneCleveland$4M
- Allan KennedyCleveland$277K
- Maria LansangCleveland$208K
- Christian NasrCleveland$205K
- Sangeeta KashyapCleveland$158K
- Amir HamrahianCleveland$139K
- Adi MehtaCleveland$120K
- Betul HatipogluCleveland$82K
- Willy Valencia RodrigoCleveland$63K
- Robert ZimmermanCleveland$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.